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Creatine plays a role in energy storage and transport/shuttle of high-energy phosphate in heart, brain, retina, testis and skeletal muscle. These
tissues take creatine from the plasma via a 2Na+/1Cl−/1creatine cotransporter (CRT). We have previously demonstrated that renal apical membrane
presents a 2Na+/1Cl−/1creatine cotransport activity. The goal of this study was to determine whether this transporter is ontogenically regulated.
Na+/Cl−/creatine transport activity was evaluated by measuring [14C]-creatine uptake into renal brush-border membrane vesicles. CRT mRNA
expression was measured by Northern and real-time PCR assays. E20 foetuses, newborn, suckling, weaning and adult (2- and 8-month-old) Wistar
rats were used. The results revealed that neither the vesicular volume, the binding of creatine to the brush-border membrane vesicles, nor the purity
of the brush-border membrane vesicle preparations was affected by maturation. Fetal and neonatal kidneys contained a creatine transporter that
was qualitatively indistinguishable from that in the adult: it was concentrative, Na+- and Cl−-dependent, electrogenic and inhibited by
guanidinopropionic acid. Maturation increased this transport activity by increasing the maximal rate of transport (Vmax) without significantly
changing the apparent Km. Northern analysis revealed two transcripts for CRT of 2.7 kb and 4.2 kb in all the ages tested. Northern and real-time
PCR assays showed that, as seen with NaCl-dependent creatine transport activity, maturation increased CRT mRNA expression. This study reports
for the first time that: (i) an apical renal Na+/Cl−/creatine cotransporter is already active in rat foetuses and (ii) development regulates Na+/Cl−/
creatine cotransport activity by increasing the density and/or turnover of the transporters.
© 2007 Elsevier B.V. All rights reserved.Keywords: Development; Kidney; Epithelia; Creatine1. Introduction
Creatine acts as energy storage and transports/shuttles high-
energy phosphate in heart, brain, retina, testis and skeletal
muscle [1,2]. Since these tissues do not synthesize their own
creatine, or do so to a limited extent [3], they take the creatine
from the plasma via a specific creatine transporter (CRT) [for
reviews see [4,5]. The physiological relevance of creatine is
strengthened by the observation that inherited defects in creatine
biosynthesis and transport are related to the development of
myopathies, mental retardation and other diseases [see [5,6]. In
addition, X-linked genetic diseases, showing defects in the
human CRT gene (SLC6A8) [7–9] have been discovered.
Body creatine homeostasis is achieved by at least three
mechanisms: uptake from the diet, endogenous biosynthesis☆ Development of Renal Creatine transport.
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of their creatine requirement by dietary intake, though on a
creatine-free diet they are able to cover it completely by endo-
genous biosynthesis [1]. The kidney efficiently salvages crea-
tine from the urine and adult human on a creatine-free diet
excrete little creatine, whereas notable quantities of it are
excreted under high dietary creatine intake, fasting and other
muscle mass-reducing conditions [1].
Athletes use oral creatine supplementation to improve
performance and recent evidence indicates that creatine may
be useful to prevent and/or treat neurodegenerative and
cardiovascular pathologies [10,11], diseases such as Parkin-
son's, Huntington's, mitochondrial cytopathies, and in hypoxia
conditions and energy-related brain pathologies [12–14]. Also,
creatine and creatine analogs, such as cyclocreatine, have been
proved to be potent anticancer agents [5,15]. However, as
pointed out by Wyss and Schulze [11], these results, as well as
a thorough evaluation of the safety of oral creatine supple-
mentation, require further confirmation in clinical studies in
humans.
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localization and regulation of the creatine transporter is needed
for understanding the mechanisms of action of creatine as well
as for designing adequate pharmacological and nutritional
interventions. In this regard there is little information on
epithelial creatine transport. We previously reported that a
2Na+/1Cl−/creatine cotransport activity is present in the apical
membrane of rat renal and small intestinal epithelia [16,17].
More recently, Tosco et al. [18] also reported an apical
membrane 2Na+/1Cl−/creatine transporter in rat jejunum. The
current study investigates the ontogeny of this transport system
in rat kidney, using renal brush-border membrane vesicles
(BBMV) isolated from foetuses, newborn, suckling, weaning
and adult rats. The results revealed that at all the ages tested,
creatine is transported into an osmotically active space by an
uphill, electrogenic, Na+- and Cl−-dependent and specific
process. The only apparent differences between the fetal and
adult creatine transport system were in the magnitude of both
maximal rate of transport (Vmax) and of CRTmRNA expression.
2. Materials and methods
2.1. Animals
Litters of 10–14 Wistar rats were born on days 22–23 of gestation. 20-day
gestation foetuses (E20), newborn (less than 1-day postpartum), suckling (15-
day-old), weaning (30-day-old) and adult (2- and 8-month-old) rats were used.
Mothers and adult rats were fed with a rat chow diet (Panlab 04) ad libitum and
had free access to water.
Rats were anesthetized with intraperitoneal injection of pentobarbital
(50 mg/kg). The experiments were performed in accordance with national/
local ethical guidelines.
2.2. Creatine uptake experiments
Brush-border membrane vesicles (BBMV) were isolated from the whole
kidney by MgCl2 precipitation, following the method of Biber et al. [19] as
described by us [16]. Unless otherwise stated, the BBMVwere loaded with a pH
7.5 buffer consisted, in mM, of 200 mannitol, 50 Kgluconate and 50 HEPES–
Tris. Except where indicated otherwise the uptake buffer contained, in mM: 100
mannitol, 100 NaCl, 50 HEPES–Tris (pH 7.5), 0.025 valinomycin and 5 μM
[14C]-creatine. Valinomycin was dissolved in DMSO (0.5% v/v) and the vehicle
alone had no effect on creatine transport measurements. Protein was measured
by the method of Bradford [20] using γ-globulin as the standard.
Creatine uptake was measured at 25°C by a rapid filtration technique.
Briefly BBMVwere left to stand at room temperature (approximately 25 °C) for
10 min. Timed incubations at room temperature were initiated by adding 10 μl
(200–250 μg of protein) of membrane vesicles suspension to 90 μl of uptake
buffer. After designated periods of time, uptake was terminated by the addition
of 1 ml of an ice-cold solution of the same composition as that of the
intravesicular buffer (stop solution). The samples were immediately filtered
under vacuum through a 0.45-μm pore size Millipore filter pre-wetted with the
stop solution. Filters were further washed with 5 ml of ice-cold stop solution,
dissolved in 5 ml of Ready-Protein (Beckman) scintillation fluid and the
radioactivity determined by liquid scintillation spectrometry. Non-specific
isotope binding to the filters was determined separately by adding stop solution
to the vesicles before addition of uptake buffer, and subtracted from the total
radioactivity of each sample. All experiments were done in triplicate.
2.3. Enzyme activity assays
The enrichment factor of alkaline phosphatase activity, a brush-border
membrane enzyme marker, and that of Na+–K+–ATPase activity, a basolateralmembrane enzyme marker, were assessed to determine the purity of the BBMV
preparations. The assays were performed at 25 °C. Na+–K+–ATPase activity
was assayed by the method of Colas and Maroux [21], using 0.2 mM SCH
28080 to block apical ouabain-sensitive H+,K+–ATPase. Alkaline phosphatase
activity was measured using Alkaline Phosphatase reagent and following the
manufacturer's instructions (Sigma Procedure No. 245). Protein was measured
as indicated above.
2.4. RNA preparation and Northern blotting
Total RNAwas extracted from whole kidney as described by Chomczynski
and Sacchi [22] and Poly (A+)RNAwas isolated by the method of Badley et al.
[23] as previously reported by us [24]. Riboprobes were generated from a rat
cDNA fragment as described [17]. Relative quantification of mRNA expression
was determined with a phosphoimager system (Fuji Photo Film Co., Ltd.) using
the PCBAS program (Raytest GmbH). In each blot, levels of CRT mRNAwere
normalized to levels of cyclophilin mRNA.
2.5. Relative quantification of real-time PCR
Total RNA was extracted from the renal cortex and medulla of rats of
different ages using RNeasy® kit (Qiagen). cDNAwas synthesized from 1 μg of
total RNA using QuantiTest® reverse transcription kit (Qiagen) in 20 μl reaction
volume as described by the manufacturer. Real-time PCR was performed with
iQ™SYBR® Green Supermix (Biorad), 0.4 μM primers and 1 μl cDNA. Con-
trols were carried out without cDNA. Amplification was run in a MiniOpticon™
System (BioRad) thermal cycler at 94 °C for 3 min followed by 35 cycles of
94 °C for 40 s, 58 °C for 40 s, and 72 °C for 40 s. Following amplification, a
melting curve analysis was performed by heating the reactions from 65 to 95 °C
in 1 °C intervals while monitoring fluorescence. Analysis confirmed a single
PCR product at the predicted melting temperature. Primers for CRT1 were based
upon the published sequence of rat CRT [25] and were antisense, 5′-TTCTA-
TTACCTGGTCAAGTCCT-3′ and sense, 5′-GCCTCAAGACTTTGTTCTCC-
3′. β-actin and GAPDH served as reference genes and were used for samples
normalization. The primer sequences for β-actin were: antisense: 5′-ACCCA-
CACTGTGCCCATCTA-3′, sense: 5′-CGGAACCGCTCATTGCC-3′ and for
GAPDH, antisense: 5′-TGCACCACCAACTGCTTAGC-3′, sense: 5′-GGCAT-
GGACTGTGGTCATGAG-3′. The cycle at which each sample crossed a fluo-
rescence threshold, Ct, was determined, and the triplicate values for each cDNA
were averaged. Analyses of real-time PCR were done using the comparative Ct
method with the Gene Expression Macro software supplied by BioRad.
2.6. Chemicals
[14C]-creatine was purchased from Amersham Radiolabel Chemicals, Inc.
Unless otherwise indicated, the other reagents used in the current study were
obtained from Sigma Chemical Co., Madrid, Spain.
2.7. Statistical analysis
Transport experiments, Northern, real-time PCR and enzyme assays were
performed on at least three animals per age. Individual transport and enzyme
measurements were carried out in triplicate. Data are presented as mean±SEM
for n separated animals. In the figures, the vertical bars that represent the SEM
are absent when they are less the symbol height. Comparison between different
experimental groups was evaluated by the two-tailed Student's t-test.
Differences were set to be significant for pb0.05. Two-way ANOVA followed
by Newman–Keuls test (pb0.05) was used for multiple comparisons.3. Results
3.1. Purity of the BBMV preparations
The quality of the BBMV preparations isolated from rats of
different ages was evaluated by measuring activities character-
Table 1
Effect of maturation on alkaline phosphatase and Na+–K+–ATPase activities (in nmol/mg protein/min) in homogenates and BBM obtained from rat kidney
Animals Alkaline phosphatase Na+–K+–ATPase
Homogenate (H) BBM Enrichment (BBM/H) Homogenate (H) BBM Enrichment (BBM/H)
Fetuses 32±2 694±70 21±1 26±2 54±1 2.1±0.1
Newborn 82±8⁎ 1350±60⁎ 16±1.2 30±1 60±1.2 2±0.1
Suckling 90±8⁎ 1577± 110⁎ 17±1 44±1.5⁎ 79±2⁎ 1.8± 0.1
Weaning 139±11⁎ 2628±118⁎ 17±2 55±2⁎ 99±2.1⁎ 1.8±0.2
2-month-old 196±8⁎ 2861±118⁎ 15±0.5 41±2⁎ 62±2⁎ 1.5±0.2
8-month-old 98±6⁎ 1625±120⁎ 16±1 36±2⁎⁎ 43±2⁎ 1.2±0.2
Means±SEM. The number of animals used per age was 3. ⁎pb0.001 as compared with foetuses. Two-way ANOVA showed an effect of maturation (pb0.001) on
enzyme activity.
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membranes, Na+–K+–ATPase (Table 1). The homogenate and
BBMV's specific activity of the alkaline phosphatase was
approximately 5-fold higher in the adult kidney as compared to
that measured in rat foetuses (Table 1). Specific activity of the
Na+–K+–ATPase slightly increased with age. The enrichments
factors, however, were not significantly affected by maturation.
The 15- to 17-fold enrichment of alkaline phosphatase
activity and the 1.8- to 2-fold enrichment of Na+–K+–ATPase
indicate quite pure BBM preparations. Contamination of the
BBM preparations with basolateral membranes was very low,
since the ratio of alkaline phosphatase enrichment/ Na+–K+–
ATPase enrichment was 7 to 8.5.
3.2. Binding of [14C]-Creatine vs. age
The effect of intravesicular volume on equilibrium [14C]-
creatine uptake (120 min) was examined to determine whether
creatine uptake into BBMV represents transport and/or substrate
binding to the membrane. As depicted in Fig. 1, creatine uptake
was inversely related to medium osmolarity in BBMV prepared
from 15-day-old and 2-month-old rat kidneys. Both types of
vesicles were osmotically reactive, indicating that creatine is
transported into an osmotically active space. The intercept on theFig. 1. Creatine uptake into renal BBMV vs. external osmolarity. The compo-
sition of the buffers is given in Materials and methods. Medium osmolarity was
increased by the addition of mannitol. 5 μM [14C]-creatine uptake into BBMV
isolated from suckling and adult rats was measured during 120 min. Line was
calculated by linear regression analysis. Each point represents the mean±SEM
of 3 separated animals per age.ordinate (zero intravesicular volume) is a measure of non-specific
binding. In both cases, the binding represents 25% of the creatine
uptake measured under standard conditions (350 mosM).
From the known extravesicular creatine concentration and
assuming an equilibrium distribution of creatine at 120 min, the
intravesicular volume was calculated. At 350 mosM, the
intravesicular volume of the renal BBMV from both, 15-day-
old and 2-month-old rats was 1.2±0.1 μl/mg protein.
3.3. Creatine uptake into renal BBMV isolated from
E20-foetuses and newborn rats
In 2001 [16] we reported that the renal apical membranes of
2-month-old rats present a concentrative 2Na+/1Cl−/creatine
cotransport system. To find out whether this transport system
was active in fetal and newborn kidney we measured the time-
course of creatine uptake in BBMV isolated from fetal and
newborn kidney (Fig. 2). An inside directed NaCl chemical
gradient was created by adding NaCl to the extravesicularFig. 2. Time-course of creatine uptake into renal BBMV isolated from foetuses
and newborn rats. 5 μM [14C]-creatine uptake was measured as a function of
time, in the absence (open symbols) (NaCl isosmotically replaced by
Kgluconate) and presence (closed symbols) of both, an inwardly directed NaCl
gradient and an inside negative membrane potential. The composition of the
intravesicular buffer is given inMaterials and methods. Each point represents the
mean±SEM. The number of animals used per age was 3. Two-way ANOVA
showed an effect of maturation (pb0.001). Newman–Keuls test: “a”, as com-
pared with nominally NaCl-free conditions. “b”, as compared with foetuses.
Fig. 3. Effect of electrical, Na+ andCl− chemical gradients and 1mMGPAon 5μM
[14C]-creatine uptake. Uptake was measured during 5 s in BBMV isolated from
foetuses and newborn rats. The uptake buffer contained (in mM): 50 HEPES–Tris
(pH 7.5), 0.025 valinomycin and either 100 mannitol, 100 NaCl (electrical and
NaCl gradient), or 50 Kgluconate and 100 NaCl (only chemical NaCl gradient)
or 50 Kgluconate and 100 Nagluconate (only chemical Na+ gradient) or 50
Kgluconate and 100 NMGCl (only Cl− gradient) or 50 Kgluconate and 200
mannitol (without gradients). The composition of the intravesicular buffer is given
in Materials and methods. Each point represents the mean±SEM. The number of
animals used per age was 3. ⁎pb0.001, as compared with electrochemical NaCl
gradient conditions.
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inside negative electrical membrane potential was created by an
outwardly directed K+ gradient in the presence of valinomycin.
In both BBMV preparations, the presence of electrochemical
NaCl gradients induced a rapid uptake of creatine, that reached
a maximum in 1 min. Thereafter, as the original electrochemical
ion gradients dissipate, there was a net efflux of creatine. No
transient accumulation was observed when Kgluconate replaced
isosmotically extravesicular NaCl, that is in the absence of
electrochemical NaCl gradients. The observation of an
overshoot of the intravesicular creatine concentration above
its equilibrium value indicates that the fetal and newborn brush-
border preparations are capable of catalyzing concentrative
uptake of creatine in the presence of NaCl gradient and
electrical membrane potential.
Fig. 2 also reveals that in the presence of extravesicular
NaCl, creatine uptake increased linearly up to 15 s. On the bases
of these results a 5-s incubation time was adopted to determine
the initial rate of creatine uptake into BBMV.
3.4. Effect of guanidinopropionic acid (GPA), Na+ and Cl−
chemical gradient and electrical membrane potential on
creatine uptake in BBMV
To further characterize the fetal and newborn renal creatine
transport system, we investigated the effects of either electrical
membrane potential, or Na+ or Cl− chemical gradients on
creatine uptake in fetal and newborn BBMV (Fig. 3). An inside
directed NaCl chemical gradient and an inside negative elec-
trical membrane potential were generated as described above.
When required, the voltage across the membrane was clamped at
zero by equal internal and external K+ concentrations in the
presence of valinomycin. The Na+, Cl− and NaCl chemical
gradients were abolished by their isosmotic replacement with N-
methyl-glucamineCl, Nagluconate or Kgluconate, respectively.
Fig. 3 reveals that clamping the membrane voltage at zero
(50 mM Ki
+ =50 mM Ko
+, plus valinomycin) inhibited creatine
uptake, indicating that the process is electrogenic. This
inhibition was further increased when the vesicles were
incubated in media nominally free of either Na+ or Cl−. The
inhibition induced by the absence of either Na+ or Cl− from the
incubation buffer was not different from that seen in vesicles
incubated under NaCl-free conditions. These observations
indicate that transport of creatine requires the presence of Na+
and Cl− ions in the incubation buffer.
GPA, a high-affinity substrate of CRT, inhibited creatine
uptake to values observed under NaCl-free conditions.
The same inhibitory profile as described here was previously
observed for creatine uptake in renal BBMV isolated from 2-
month-old rat [16].
3.5. Creatine uptake vs. age
Creatine uptake was measured in renal BBMVobtained from
foetuses, newborn, suckling, weaning, 2-month-old and 8-
month-old rats. The time of uptake was either 5 s (initial rate) or
1 min (at the overshoot). In the presence of both, NaCl in theincubation buffer and an inside negative membrane potential,
the initial rate of creatine uptake into fetal BBMV was 10.4±
2 pmol/mg protein/5 s and this rate of transport gradually
increased with age, reaching maximal values at 2-month-old
rats (65±3 pmol/mg protein/5 s) (Fig. 4). This represents a 6-
fold increase in the rate of creatine transport with maturation.
When uptake was measured during 1 min, the maturation
induced a 7.6-fold increase in creatine transport. As the
calculated intravesicular volume was 1.2 μl/mg protein, at 5 s
the resulting accumulation was 8.7 μM and 54 μM for foetuses
and 2-month-old rat, respectively.
In the absence of an inwardly directed NaCl gradient,
creatine uptake into BBMV was negligible and it was not
affected by age (Fig. 4).
Table 2
Kinetic parameters of the NaCl-dependent creatine uptake system measured in
renal BBMV isolated from rats of different ages.





Means±SEM. The number of animals used per age was 4. ⁎pb0.001, ⁎⁎pb0.01
as compared with newborn values. Two-way ANOVA showed an effect of
maturation (pb0.001) on Vmax values.
Fig. 5. Creatine uptake vs. its extravesicular concentration. 5 s creatine uptake
was measured in BBMV isolated from newborn (■), suckling (▲), weaning (○)
and 2-month-old (●) rats in NaCl-containing (total uptake) and in nominally
NaCl-free incubation buffers. Data represent total uptake minus that measured in
nominally NaCl-free buffers. Insert: Eadie–Hofstee plots of the saturable
components. Means±SEM. 4 animals were used per age.
Fig. 4. Renal Na+/Cl−/creatine uptake vs. animal age. 5 μM [14C]-creatine
uptake was measured in renal BBMV isolated from foetuses, newborn, suckling,
weaning and adult rats, during either 5 s (initial rate) or 1 min (overshoot). The
measurements were carried out in the absence (open symbols) (NaCl
isosmotically replaced by Kgluconate) and presence (closed symbols) of both,
an inwardly directed NaCl gradient and an inside negative membrane potential.
Means±SEM. The number of animals used per age was 5. Two-way ANOVA
showed an effect of maturation (pb0.001). Newman–Keuls test: “a”, as
compared with nominally NaCl-free conditions. “b” as compared with foetuses.
2845M. García-Delgado et al. / Biochimica et Biophysica Acta 1768 (2007) 2841–28483.6. Kinetic study of the creatine uptake
To evaluate apparent maximal initial rate of uptake, Vmax,
and the Michaelis–Menten constant, Km, of the renal creatine
transport system, 5 s creatine uptake was measured at 2.5, 5, 10,
15, 50, 100 and 200 μM creatine in the extravesicular buffer. At
each extravesicular creatine concentration, uptake was mea-
sured in the presence and absence of both, an inwardly directed
NaCl gradient and an inside negative electrical membrane
potential. Renal BBMV were obtained from newborn, suckling,
weaning and 2-month-old rats.
The results revealed that at all the ages tested, the creatine
uptake values measured in the presence of NaCl fit best
(r=0.997) a transport model describing a single saturable
transport system plus a negligible nonsaturable diffusion
component (ENZFITTER program):
v ¼ ðVmaxS=Km þ SÞ þ KDS
where v is the initial rate of uptake; Vmax, the apparent maximal
initial rate of uptake; S, the external creatine concentration; Km,
the apparent transport constant; and KD, the apparent diffusion
constant.
In nominally NaCl-free conditions, the initial rate of creatine
uptake was negligible and it was not affected by age (data not
shown). The data shown in Fig. 5 are the difference between
total creatine uptake and that measured in the absence of
extravesicular NaCl, and represent the uptake rate mediated by
the Na+/Cl−/creatine cotransport system. The Eadie–Hofstee
plots of the latter component (Fig. 5, insert) yielded in all cases a
linear relationship and revealed that the apparent Vmax increaseswith age (Table 2). The apparent Km values, however, were
similar in all groups tested and similar to that previously
reported [16]. Both, the linearity of the Eadie–Hofstee plots,
and the equality of Km values are consistent with the existence
of a single creatine transport system in all the experimental
groups.
3.7. Northern assays and real-time PCR analysis
The effect of maturation on renal CRT mRNA expression
was examined by Northern blot hybridization using poly (A+)
RNA isolated from the whole kidney of newborn, suckling,
weaning, 2- and 8-month-old rats. Fig. 6 reveals that, as
reported earlier for rat and human [17,26,27], the antisense
riboprobes hybridized to two transcripts of 4.2 kb and 2.7 kb.
The presence of different transcripts is believed to arise from
alternative polyadenylation [27]. In all the ages tested, the
4.2-kb transcript was significantly more abundant than that of
2.7 kb. The intensity of both bands was low at birth and
increased with maturation. The 2.7-kb transcript reached adult
values in weaning rats and the 4.2-kb transcript in suckling rats.
Comparisons between adult and newborn rats revealed a 2.5- to
3-fold increase in CRT mRNA with age.
Renal levels of CRT mRNA vs. maturation were also
quantified by real-time PCR assays. In this study total RNAwas
extracted from both, renal cortex and medulla of the rats. The
results revealed that, except for adult rat kidney, CRT mRNA
Fig. 7. Real-time PCR was performed using total RNA isolated from both, the
renal cortex and medulla of foetuses, newborn, suckling, weaning and 2-month-
old rats. Data were normalized to either β-actin or GAPDH. Histograms
represent the arbitrary units of CRT expression vs. age, of at least three animals
per age. Two-way ANOVA showed an effect of maturation on renal cortex and
medulla CRT expression (pb0.001). Newman–Keul's test: “a” as compared
with renal cortex and medulla expression in foetuses. “b’’, as compared with
medullar expression.
Fig. 6. Northern blot analysis of renal CRT mRNA obtained from rats of
different ages. 10 μg of poly(A+) RNA, obtained from the whole kidney, were
loaded onto the gel per lane. Data were normalized relative to cyclophilin. The
size of the transcripts was determined by ribosomal RNA. The CRT transcripts
displayed a motility corresponding to a size of ca. 4.2 and 2.7 kb. Histograms
represent the arbitrary units of CRT mRNA expression vs. age. Two-way
ANOVA showed an effect of maturation on the expression of the two transcripts
(pb0.001). Newman–Keul's test: “a”, as compared with 4.2 kb transcript in the
newborn rats. “b”, as compared with 2.7 kb transcript in the newborn rats.
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and that it increased with maturation (Fig. 7). These observa-
tions may suggest that in the early stages of life, renal creatine
transport across the apical membrane was higher in the renal
cortex than in the medulla.
4. Discussion
The kidney plays a dual role in body creatine homeostasis
since it: (i) contains the largest amount of the L-arginine: glycine
amidinotransferase [28], which catalyzes the first reaction in
creatine biosynthesis and (ii) efficiently reabsorbs the filtered
creatine, as indicated by the low rates of creatine urinary
excretion in vegetarians, who hardly have any creatine in their
diet [29].
Creatine crosses the apical membrane of renal epithelia via a
2Na+/1Cl−/1creatine cotransporter [16]. Although renal CRT1
mRNA expression has been observed in rat E18.5 [30], to our
knowledge no data are currently available regarding at what
stage of nephrogenesis this cotransporter is first functional and
at what stage its activity corresponds to that in adult animals.
This information is important given the dual role of the kidney
in body creatine homeostasis. Herein, we investigate these
questions by Northern and real-time PCR assays and bymeasurements of creatine uptake into renal brush-border
membrane vesicles, using kidneys of fetal, newborn, suckling,
weaning and adult rats.
The present study shows for the first time that a functional
creatine transporter is already present in the renal apical
membrane of foetuses and newborn rats. This transport activity
is similar to that measured in adults [16]: it is Na+- and Cl−-
dependent, accumulative, electrogenic, and inhibited by GPA.
There are two significant quantitative differences: (a) the ability
of the vesicles to take up creatine is much lower in the fetal and
newborn preparations as compared with adults (Fig. 4) and (b)
the Vmax in the newborn BBMV is significantly less than that
determined for the adult (Table 2).
Specific and non-specific factors may contribute to the
maturation-induced increase in the renal Na+/Cl−/creatine
transport activity. The latter may include differences in kidney
weight, in purity and volume of the BBMV and in the creatine
binding to the vesicles. Among the specific changes are:
(i) different capacity of the vesicles to concentrate creatine,
consequent to changes in dissipation of the electrochemical Na+
gradient; (ii) replacement of one transporter isoform by another;
(iii) changes in the density of transporters; and (iv) changes in
turnover rate of the transporter.
An increase in kidney weight cannot explain the observed
maturation-induced increase in Na+/Cl−/creatine transport
activity because NaCl-independent creatine uptake was not
affected by age and, more important, the uptake values were
referred to mg of protein. As all the BBMV preparations have
the same enrichment factors, creatine binding to the membrane
and intravesicular volume values, the observed maturation-
induced differences in renal creatine transport activity appar-
ently reflect true developmental changes in transport activity, as
the neonatal kidney matures and adapts to the needs of the
growing organism.
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capacity of the BBMV to concentrate creatine can be excluded
because creatine uptake was also measured at initial rates (see
Fig. 4). A maturation-related expression of different transporter
isoforms can also be discarded, because the apparent Km does
not change with age. However, ageing increases Vmax, indi-
cating that renal maturation may increase the density of creatine
transporters and/or their turnover rate.
The turnover rate of membrane carriers is affected by
membrane fluidity and age-dependent reductions in membrane
fluidity have been observed in brush-border membranes of rat
kidney, which were accompanied by a decrease in the Vmax
for Na+/phosphate [31] and by an increase in the Vmax of
Na+/glucose [32] cotransport activities, with no change in their
Km. Therefore, an effect of membrane fluidity on the turnover
rate of Na+/Cl−/creatine cotransporters, and hence on the Vmax,
cannot be discarded.
The current results corroborate a previous report [30]
showing that fetal kidney expresses CRT mRNA and reveal
that this CRT mRNA expression is up-regulated by maturation.
The current results also revealed that the same two CRT mRNA
transcripts are present at all the ages studied. These observations
suggest that transcriptional mechanisms are involved in the
ontogeny of renal Na+/Cl−/creatine transport system and
support the view that the maturation-induced increase in
Na+/Cl+/creatine transport activity is mediated, at least in part,
by an increase in the number of Na+/Cl−/creatine transporters at
the apical membrane.
In rat the genes coding for renal transporters are up-regulated
mainly after birth, reaching relatively high levels of expression
in the adult [33]. However, different transport systems differ in
their pattern of activity during ontogeny. Thus, the epithelial
Na+ channel protein (ENaC) is already present in rats by the
16th day of gestation and its abundance reaches nearly adult
values by the 22nd day of fetal life [34]. In the rabbit, the
activity of the Na+,K+, ATPase increased 2.5-fold between the
2nd and 6th week of life [35]. On the other hand, renal NaPi
cotransport activity in guinea pigs [36], and that of thiamin in
mice kidney [37] decreased with maturation.
Contrary to what is reported here, NaCl-dependent creatine
uptake in rat intestine was maximal in newborn rats and it
decreased with age [38].These observations indicate that NaCl/
creatine uptake by intestinal and renal epithelia respond
differently to ontogeny. Ontogeny also up regulates creatine
biosynthesis, since the L-arginine: glycine amidinotransferase
activity of rat kidney increases rapidly after birth, reaching adult
levels at 4 days of age [28]. Additionally, from rat E12.5 to
E18.5, L-arginine:glycine amidinotransferase and guanidinoa-
cetate methyltransferase mRNAs expression progressively
acquire their adulthood pattern [30].
Therefore, at the early stage of life, when the demand for
creatine may exceed the endogenous biosynthesis capacity, rat
pups receive most of their creatine from the mother milk and
the intestine presents an active NaCl-dependent creatine
transporter. The foetus may obtain its creatine from the am-
niotic fluid and from the mother, since maternal–fetal transport
of creatine has been demonstrated [39,40]. In the growingrat, however, the increase in endogenous creatine synthesis,
renal creatine reabsorption and intestinal surface area, that
would allow a significant paracellular transport of creatine
[38,41], might be sufficient to maintain normal plasma creatine
levels and its intestinal NaCl/creatine transport activity is
reduced.
Therefore, up-regulation of renal creatine biosynthesis and
transport are accompanied by down-regulation of intestinal
creatine Na+/Cl−/creatine cotransporter.
In conclusion, this is the first report showing that (i) fetal and
neonatal rat kidneys have an apical membrane NaCl-dependent
creatine transport activity that is qualitatively indistinguishable
from that in the adult and (ii) both the activity and expression of
this transporter is ontogenically regulated.
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